Medici Bioventures PLC
03 April 2006
Medici Bioventures plc
Statement re suspension
The Directors announce that, in accordance with the guidance note to AIM Rule 8,
Medici Bioventures plc ('the Company') has been suspended pursuant to AIM Rule
40.
Since publication of the Company's interim results to 31 December 2005, the
Directors have continued to review a number of investment opportunities but none
have been viewed suitable or met their investment strategy. The Directors will
continue to review opportunities with the objective of completing a reverse
takeover in accordance with the requirements of the AIM Rules.
In accordance with the guidance note to AIM Rule 8, trading in the Company's
shares on AIM will be cancelled pursuant to AIM Rule 41 if the Company does not
complete a reverse takeover within 6 months of its suspension.
Anthony Barton
Chairman
This information is provided by RNS
The company news service from the London Stock Exchange